Point72 Asset Management
AUPH icon

Point72 Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Point72 Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-849,621
Closed -$7.63M – 2033
2024
Q4 		$7.63M Buy
+849,621
New +$6.93M 0.02% 796
2023
Q3 		– Sell
-544,720
Closed -$5.27M – 2459
2023
Q2 		$5.27M Sell
544,720
-1,395,253
-72% -$14.5M 0.02% 801
2023
Q1 		$21.3M Sell
1,939,973
-243,173
-11% -$2.14M 0.07% 345
2022
Q4 		$9.43M Buy
+2,183,146
New +$12.7M 0.03% 565
2021
Q2 		– Sell
-314,565
Closed -$4.08M – 962
2021
Q1 		$4.08M Sell
314,565
-1,824,896
-85% -$26.5M 0.02% 608
2020
Q4 		$29.6M Sell
2,139,461
-204,290
-9% -$2.97M 0.14% 199
2020
Q3 		$34.5M Sell
2,343,751
-1,499,990
-39% -$21.7M 0.18% 154
2020
Q2 		$62.5M Sell
3,843,741
-825,602
-18% -$13.2M 0.41% 62
2020
Q1 		$67.8M Buy
4,669,343
+1,073,710
+30% +$18.9M 0.55% 36
2019
Q4 		$72.8M Buy
3,595,633
+3,573,880
+16,429% +$32.9M 0.38% 65
2019
Q3 		$116K Sell
21,753
-330
-1% -$2K ﹤0.01% 969
2019
Q2 		$145K Buy
22,083
+19,216
+670% +$122K ﹤0.01% 1004
2019
Q1 		$19K Buy
+2,867
New +$19K ﹤0.01% 984
2018
Q1 		– Sell
-537,000
Closed -$2.43M – 932
2017
Q4 		$2.43M Buy
+537,000
New +$2.98M 0.01% 706

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Point72 Asset Management's AUPH Position: Q1 2025 in Review

Point72 Asset Management sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2025, closing a stake of 849,621 shares — an estimated $7.63M sold.

Point72 Asset Management first reported a position in AUPH in Q4 2017 and held it in 14 quarters. The position peaked at $72.8M in Q4 2019. 214 funds tracked by Wall St. Rank hold AUPH as of Q1 2025.

  • Point72 Asset Management reported no remaining Aurinia Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Point72 Asset Management sold 849,621 Aurinia Pharmaceuticals shares in Q1 2025, an estimated $7.63M.
  • Point72 Asset Management first reported a position in Aurinia Pharmaceuticals in Q4 2017 and held it in 14 quarters.
  • Point72 Asset Management's Aurinia Pharmaceuticals position peaked at $72.8M in Q4 2019.
  • 214 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2025.

Based on Point72 Asset Management's 13F filing for Q1 2025, filed 15 May 2025.